Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 18Carcinoma, Hepatocellular 8Liver Neoplasms 7Colorectal Neoplasms 3Unresectable Pancreatic Cancer 2Stomach Neoplasms 2Neoplasm Metastasis 2Locally Advanced Pancreatic Cancer 2Cholangiocarcinoma 2Solid Tumor Including Thyroid, Bone, Liver, Pancreas 1Rectal Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Pancreatic Adenocarcinoma Resectable 1Pancreatic Adenocarcinoma Locally Advanced 1Liver Metastasis Colon Cancer 1Liver Diseases 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Colorectal Liver Metastases 1Bile Duct Neoplasms 1Advanced Gastric Cancer 1

Interventions

apatinib 9Paclitaxel 9Capecitabine 7Oxaliplatin 6camrelizumab 5Cisplatin 5S 1 (combination) 4Fluorouracil 3Docetaxel 3130-nm albumin-bound paclitaxel 3titanium silicide 2Leucovorin 2Drug Therapy 2vorolanib 1trifluridine tipiracil drug combination 1tipiracil 1spartalizumab 1rucaparib 1relatlimab 1raltitrexed 1pazopanib 1olaparib 1lobaplatin 1linrodostat 1ezogabine 1endostar protein 1durvalumab 1dacomitinib 1capivasertib 1Trifluridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Gastric Cancer × Electroporation × Gastrointestinal × Clear all
NCT03350477 2019-01-25

Bioinformation Therapy for Gastric Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed
120 enrolled
Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡